Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS)

Antiviral Research

Volumn 89, Issue 1, 2011, Pages 19-25

  Yebra, Gonzalo ^a   de Mulder, Miguel ^a   Martín, Leticia ^a   Pérez Cachafeiro, Santiago ^b   Rodríguez, Carmen ^c   Labarga, Pablo ^d   García, Federico ^e   Tural, Cristina ^f   Jaén, Àngels ^g   Navarro, Gemma ^h   Holguin A ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c CENTRO SANITARIO SANDOVAL   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^g HOSPITAL MÚTUA DE TERRASSA   (Spain)

^h Hospital Universitari Parc Taulí   (Spain)

Author keywords

HIV 1 non B subtypes; Phylogenetic analysis; Recombinants; Subtyping tools

Indexed keywords

POL PROTEIN;

ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; PHYLOGENY; PRIORITY JOURNAL; REFERENCE DATABASE; RELIABILITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SPAIN; VIRUS RECOMBINANT; VIRUS TYPING;

AUTOMATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR TYPING; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; SENSITIVITY AND SPECIFICITY; SPAIN; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78650880188     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.10.008     Document Type: Article

References (41)

1. Baeten J.M., Chohan B., Lavreys L., Chohan V., McClelland R.S., Certain L., Mandaliya K., Jaoko W., Overbaugh J. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J. Infect. Dis. 2007, 195:1177-1180.
2. Candotti D., Adu-Sarkodie Y., Davies F., Baldrich-Rubio E., Stirrups K., Lee H., Allain J.P. AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection. J. Med. Virol. 2000, 62:1-8.
3. Caro-Murillo A.M., Castilla J., Perez-Hoyos S., Miró J.M., Podzamczer D., Rubio R., Riera M., Viciana P., López Aldeguer J., Iribarren J.A., de los Santos-Gil I., Gomez-Sirvent J.L., Berenguer J., Gutiérrez F., Saumoy M., Segura F., Soriano V., Pena A., Pulido F., Oteo J.A., Leal M., Casabona J., del Amo J., Moreno S. Spanish cohort of naive HIV-infected patients (CoRIS): rationale, organization and initial results. Enferm. Infecc. Microbiol. Clin. 2007, 25:23-31.
4. Caro-Murillo A.M., Gutiérrez F., Ramos J.M., Sobrino P., Miró J.M., Lopez-Cortes L.F., Tural C., Moreno A., Gil I.D., Angoiti J.M., Camino X., Lleti M.S., Rubio R., Moreno S., del Amo J. HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006). Enferm. Infecc. Microbiol. Clin. 2009, 27:380-388. CoRIS.
5. Cuevas M.T., Muñoz-Nieto M., Thomson M.M., Delgado E., Iribarren J.A., Cilla G., Fernández-García A., Santamaría J.M., Lezaun M.J., Jiménez L., López-Soria L.M., Sota M., Contreras G., Nájera R., Pérez-Álvarez L. HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain. J. Acquir. Immune Defic. Syndr. 2009, 51:99-103.
6. Champenois K., Bocket L., Deuffic-Burban S., Cotte L., André P., Choisy P., Yazdanpanah Y. Expected response to protease inhibitors of HIV-1 non-B subtype viruses according to resistance algorithms. AIDS 2008, 22:1087-1089.
7. De Mendoza C., Garrido C., Poveda E., Corral A., Zahonero N., Treviño A., Anta L., Soriano V. Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain. AIDS Res. Hum. Retroviruses 2009, 25:967-972.
8. Frange P., Galimand J., Vidal N., Goujard C., Deveau C., Souala F., Peeters M., Meyer L., Rouzioux C., Chaix M.L. New and old complex recombinant HIV-1 strains among patients with primary infection in 1996-2006 in France: the French ANRS CO06 primo cohort study. Retrovirology 2008, 5:69.
9. Galán J.C., Aguilera A., González-Alba J.M., Rodríguez-Calviño J.J., Moldes Suárez L.M., Pérez-Elías M.J., Regueiro B. Can the rapid subtyping tools identify the increasing new HIV-recombinant forms?. 7th European HIV Drug Resistance Workshop 2009.
10. Gifford R., de Oliveira T., Rambaut A., Myers R.E., Gale C.V., Dunn D., Shafer R., Vandamme A.M., Kellam P., Pillay D. Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity. AIDS 2006, 20:1521-1529.
11. Gonzalez L.M., Santos A.F., Abecasis A.B., Van Laethem K., Soares E.A., Deforche K., Tanuri A., Camacho R., Vandamme A.M., Soares M.A. Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates. J. Antimicrob. Chemother. 2008, 61:1201-1204.
12. Gottesman B.S., Grosman Z., Lorber M., Levi I., Shitrit P., Mileguir F., Gottesman G., Chowers M.Y. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load. J. Med. Virol. 2004, 73:167-171.
13. Grossman Z., Paxinos E.E., Averbuch D., Maayan S., Parkin N.T., Engelhard D., Lorber M., Istomin V., Shaked Y., Mendelson E., Ram D., Petropoulos C.J., Schapiro J.M. Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. Antimicrob. Agents Chemother. 2004, 48:2159-2165.
14. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006, 20:w13-23.
15. Holguín Á., Sune C., Hamy F., Soriano V., Klimkait T. Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure. J. Clin. Virol. 2006, 36:264-271.
16. Holguín Á., de Mulder M., Yebra G., López M., Soriano V. Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain. Curr. HIV Res. 2008, 6:327-334.
17. Holguín Á., López M., Molinero M., Soriano V. Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants. J. Clin. Microbiol. 2008, 46:2918-2923.
18. Holguín Á., López M., Soriano V. Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms. J. Clin. Microbiol. 2008, 46:3896-3899.
19. Holguín Á., Lospitao E., López M., de Arellano E.R., Pena M.J., del Romero J., Martín C., Soriano V. Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools. J. Med. Virol. 2008, 80:383-391.
20. Kantor R., Katzenstein D. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution. AIDS Rev. 2003, 5:25-35.
21. Kim J.E., Beckthold B., Chen Z., Mihowich J., Malloch L., Gill M.J. Short communication: identification of a novel HIV type 1 subtype H/J recombinant in Canada with discordant HIV viral load (RNA) values in three different commercial assays. AIDS Res. Hum. Retroviruses 2007, 23:1309-1313.
22. Kinomoto M., Appiah-Opong R., Brandful J.A., Yokoyama M., Nii-Trebi N., Ugly-Kwame E., Sato H., Ofori-Adjei D., Kurata T., Barre-Sinoussi F., Sata T., Tokunaga K. HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors. Clin. Infect. Dis. 2005, 41:243-251.
23. Korn K., Weissbrich B., Henke-Gendo C., Heim A., Jauer C.M., Taylor N., Eberle J. Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay. J. Clin. Microbiol. 2009, 47:1238-1240.
24. Loveday C., MacRae E. Limitations in using online tools to determine HIV-1 subtype in clinical patients: a comparison of 5 tools. Antivir. Ther. 2006, 11:S129.
25. Ntemgwa M., Gill M.J., Brenner B.G., Moisi D., Wainberg M.A. Discrepancies in assignment of subtype/recombinant forms by genotyping programs for HIV type 1 drug resistance testing may falsely predict superinfection. AIDS Res. Hum. Retroviruses 2008, 24:995-1002.
26. Plantier J.C., Leoz M., Dickerson J.E., De Oliveira F., Cordonnier F., Lemee V., Damond F., Robertson D.L., Simon F. A new human immunodeficiency virus derived from gorillas. Nat. Med. 2009, 15:871-872.
27. Rouet F., Chaix M.L., Nerrienet E., Ngo-Giang-Huong N., Plantier J.C., Burgard M., Peeters M., Damond F., Ekouevi D.K., Msellati P., Ferradini L., Rukobo S., Marechal V., Schvachsa N., Wakrim L., Rafalimanana C., Rakotoambinina B., Viard J.P., Seigneurin J.M., Rouzioux C. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J. Acquir. Immune Defic. Syndr. 2007, 45:380-388.
28. Rouet F., Foulongne V., Viljoen J., Steegen K., Becquart P., Valea D., Danaviah S., Segondy M., Verhofstede C., Van de Perre P. Comparison of the generic HIV viral load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study. J. Virol. Methods 2010, 163:253-257.
29. Sacktor N., Nakasujja N., Skolasky R.L., Rezapour M., Robertson K., Musisi S., Katabira E., Ronald A., Clifford D.B., Laeyendecker O., Quinn T.C. HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin. Infect. Dis. 2009, 49:780-786.
30. Sagir A., Oette M., Kaiser R., Daumer M., Fatkenheuer G., Rockstroh J.K., Knechten H., Schmutz G., Hower M., Emmelkamp J., Pfister H., Haussinger D. Trends of prevalence of primary HIV drug resistance in Germany. J. Antimicrob. Chemother. 2007, 60:843-848.
31. Smith M., Geretti A.M., Osner N., Easterbrook P., Zuckerman M. High levels of discordance between sequencing and serological subtyping in a predominantly non-B subtype HIV-1 infected cohort. J. Clin. Virol. 2005, 33:312-318.
32. Snoeck J., Kantor R., Shafer R.W., Van Laethem K., Deforche K., Carvalho A.P., Wynhoven B., Soares M.A., Cane P., Clarke J., Pillay C., Sirivichayakul S., Ariyoshi K., Holguin A., Rudich H., Rodrigues R., Bouzas M.B., Brun-Vezinet F., Reid C., Cahn P., Brigido L.F., Grossman Z., Soriano V., Sugiura W., Phanuphak P., Morris L., Weber J., Pillay D., Tanuri A., Harrigan R.P., Camacho R., Schapiro J.M., Katzenstein D., Vandamme A.M. Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent. Antimicrob. Agents Chemother. 2006, 50:694-701.
33. Steegen K., Luchters S., De Cabooter N., Reynaerts J., Mandaliya K., Plum J., Jaoko W., Verhofstede C., Temmerman M. Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings. J. Virol. Methods 2007, 146:178-187.
34. Van de Vijver D.A.M.C., Wensing A.M.J., Angarano G., Asjö B., Balotta C., Boeri E., Camacho R., Chaix M.L., Costagliola D., Op de Coul E.L., De Luca A., Maljkovic I., De Mendoza C., Derdelinckx I., Grossman Z., Hamouda O., Hatzakis A., Hoepelman I.M., Hemmer R., Horban A., Korn K., Kücherer C., Leitner T., Loveday C., MacRae E., Meyer L., Nielsen C., Ormaasen V., Perrin L., Paraskevis D., Puchhammer-Stockl E., Ruiz L., Salminen M., Schmit J.C.C., Schneider F., Schuurman R., Soriano V., Stanczak G., Stanojevic M., vandamme A.M., van Laethem K., Violin M., Wilbe K., yerly S., Zazzi M., Boucher C.A.B. Differences in the frequency of minor substitutions between HIV-1 subtypes and their potential impact on the genetic barrier for resistance to protease inhibitors. Antivir. Ther. 2005, 10:S145.
35. Vasan A., Renjifo B., Hertzmark E., Chaplin B., Msamanga G., Essex M., Fawzi W., Hunter D. Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin. Infect. Dis. 2006, 42:843-852.
36. Wensing A.M., van de Vijver D.A., Angarano G., Asjö B., Balotta C., Boeri E., Camacho R., Chaix M.L., Costagliola D., De Luca A., Derdelinckx I., Grossman Z., Hamouda O., Hatzakis A., Hemmer R., Hoepelman A., Horban A., Korn K., Kucherer C., Leitner T., Loveday C., MacRae E., Maljkovic I., de Mendoza C., Meyer L., Nielsen C., Op de Coul E.L., Ormaasen V., Paraskevis D., Perrin L., Puchhammer-Stockl E., Ruiz L., Salminen M., Schmit J.C., Schneider F., Schuurman R., Soriano V., Stanczak G., Stanojevic M., Vandamme A.M., Van Laethem K., Violin M., Wilbe K., Yerly S., Zazzi M., Boucher C.A. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J. Infect. Dis. 2005, 192:958-966.
37. Wilkinson E., Engelbrecht S. Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa. Infect. Genet. Evol. 2009, 9:840-846.
38. Wirden M., Tubiana R., Marguet F., Leroy I., Simon A., Bonmarchand M., Ait-Arkoub Z., Murphy R., Marcelin A.G., Katlama C., Calvez V. Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes. J. Clin. Microbiol. 2009, 47:1543-1545.
39. Yebra G., de Mulder M., del Romero J., Rodríguez C., Holguín Á. HIV-1 non-B subtypes: high transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability. Antiviral Res. 2010, 85:409-417.
40. Yerly S., von Wyl V., Ledergerber B., Boni J., Schupbach J., Burgisser P., Klimkait T., Rickenbach M., Kaiser L., Gunthard H.F., Perrin L. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS 2007, 21:2223-2229.
41. Zhang M., Foley B., Schultz A.K., Macke J.P., Bulla I., Stanke M., Morgenstern B., Korber B., Leitner T. The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 2010, 7:25.